A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new research has found. The drug, Axitinib, inhibits growth of new blood vessels in the brain -- a feature shared by both cancer tumors and Alzheimer's disease. This hallmark represents a new target for Alzheimer's therapies. Mice that underwent the therapy not only exhibited a reduction in blood vessels and other Alzheimer's markers in their brains, they also performed remarkably well in tests designed to measure learning and memory.
from Healthy Aging News -- ScienceDaily https://ift.tt/2WHvVww
No comments:
Post a Comment